US OptionsDetailed Quotes

ALEC241115C7500

Watchlist

0.70
0.000.00%

15min DelayClose Nov 5 15:59 ET

0.00High0.00Low

Alector Stock Discussion

Jaguar8

Sep 19 07:24

NEWS

$Alector (ALEC.US)$
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
Alector (Nasdaq: ALEC) presented baseline characteristics for its pivotal INFRONT-3 Phase 3 clinical trial at the 14th International Conference on Frontotemporal Dementias. The trial evaluates latozinemab, a novel monoclonal antibody, for treating frontotemporal dementia with progranulin gene mutation (FTD-GR...

Jaguar8

Jul 28 07:06

NEWS

$Alector (ALEC.US)$
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
Alector presented baseline characteristics for the INVOKE-2 Phase 2 clinical trial of AL002, a TREM2 agonist, at AAIC® 2024.
The trial, involving 381 participants with early Alzheimer's disease (AD), is the first global Phase 2 study evaluating a TREM2 agonist's safety and efficacy in slowing AD progression.
Key point...

Moomoo AI

Jan 19 13:58

Alector's low P/S ratio may be due to poor revenue performance and expectations of this trend continuing. Future revenue growth is expected to be significantly lower than the industry, possibly causing discomfort among shareholders and a drop in share price.

Little Excitement Around Alector, Inc.'s (NASDAQ:ALEC) Revenues As Shares Take 27% Pounding

Moomoo AI

Dec 12, 2023 06:41

Arnon Rosenthal's major sale indicates insiders may expect a lower price. Despite high insider ownership, the absence of insider purchases and significant sales stirs uncertainty about the company's prospects and arouses investor caution.

Alector Insiders Sell US$711k Of Stock, Possibly Signalling Caution

Moomoo AI

Oct 20, 2023 05:26

Despite declining revenue, Alector's cash runway looks promising. However, significant cash burn could necessitate capital raise, potentially diluting shareholder value. Risk factors warrant careful scrutiny before investment.

Is Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans?

Best squeeze by end of July

$SoFi Technologies (SOFI.US)$
$Alector (ALEC.US)$
$PacWest Bancorp (PACW.US)$
Who will squeeze best?

JonSnow

Jun 6, 2023 18:19

Interesting

$Alector (ALEC.US)$
All in or just a little?

Movers and Shakers

Oct 3, 2022 07:18

Columns Today's Pre-Market Stock Movers: TSLA, CS, VOD, MYOV and More

Gapping up
$Viasat (VSAT.US)$ +5.9% (the Wall Street Journal reported that the satellite company was close to a deal to sell a military communications unit to defense contractor $L3Harris Technologies (LHX.US)$ for nearly $2 billion.)
$Myovant Sciences (MYOV.US)$ +31.3% (the biopharmaceutical company rejected a bid by its largest shareholder, Sumitovant Biopharma, to buy the shares it doesn’t already own for $22.75 per share. Myovant said...

No comment yet